NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹197 Cr | ₹136 Cr | ₹83 Cr | ₹122 Cr | ₹231 Cr |
What is the latest Total Debt ratio of NEULAND LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹197 Cr |
| Mar2025 | ₹136 Cr |
| Mar2024 | ₹83 Cr |
| Mar2023 | ₹122 Cr |
| Mar2022 | ₹231 Cr |
How is Total Debt of NEULAND LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹197 Cr | 44.56 | |
| Mar2025 | ₹136 Cr | 64.85 | |
| Mar2024 | ₹83 Cr | -32.10 | |
| Mar2023 | ₹122 Cr | -47.39 | |
| Mar2022 | ₹231 Cr | - | |
Compare Total Debt of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,442.3 Cr | 2.3% | -5.4% | 14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 2.3% |
-5.4% |
14.8% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses